Clinical trial
Botswana Study of UC-781 Vaginal Microbicide
NCT00385554 · Centers for Disease Control and Prevention, U.S. Fed · Withdrawn
Key facts
| NCT number | NCT00385554 |
|---|---|
| Title | Botswana Study of UC-781 Vaginal Microbicide |
| Official title | Phase I Trial of the Safety, Toxicity, and Acceptability of the Microbicide UC-781 When Topically Applied by HIV-uninfected Women and Men in Botswana |
| Lead sponsor | Centers for Disease Control and Prevention, U.S. Fed |
| Collaborators | CONRAD |
| Status | Withdrawn |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | HIV Infections |
| Intervention type | Drug |
| Interventions | UC-781 carbomer gel, 0.1% and 0.25% |
| Enrollment | 0 |
| First posted | Oct 9, 2006 |
| Last update posted | Aug 16, 2012 |
| Countries | Botswana, United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: